Showing results (81-90 of 209) with videos related to

Sort By:
Pageof 21
Platelets|October 27, 2025
Comparison of in-hospital net clinical outcomes of ticagrelor and clopidogrel in acute coronary syndrome patients stratified by CRUSADE score: findings from the CCC-ACS registryZuoyi Zhou, Haotai Xie, Fangfang Fan, et al.
Age and Ageing|November 22, 2022
In-hospital outcomes of ticagrelor versus clopidogrel in patients 75 years or older with acute coronary syndrome: findings from the Improving Care for Cardiovascular Disease in China (CCC)-Acute Coronary Syndrome ProjectNa Yang, Jing Liu, Jun Liu, et al.
International Journal of Cardiology|August 27, 2021
Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registryFabien Picard, Deepak L Bhatt, Grégory Ducrocq, et al.
American Heart Journal|December 15, 2010
Lipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: results from the Medications ApplIed aNd SusTAINed Over Time (MAINTAIN) registryChiara Melloni, Bimal R Shah, Fang-Shu Ou, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 7, 2004
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesScott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
Frontiers in Cardiovascular Medicine|October 17, 2022
Early ACEI/ARB use and in-hospital outcomes of acute myocardial infarction patients with systolic blood pressure <100 mmHg and undergoing percutaneous coronary intervention: Findings from the CCC-ACS projectXuedong Zhao, Guanqi Zhao, Mengge Zhou, et al.
Journal of the American College of Cardiology|September 11, 2004
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesScott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
Circulation|July 14, 2004
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesScott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
Journal of the American College of Cardiology|September 10, 2017
2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision PathwaysDonald M Lloyd-Jones, Pamela B Morris, Christie M Ballantyne, et al.
Circulation|March 30, 2006
Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary interventionAlice K Jacobs, Elliott M Antman, Gray Ellrodt, et al.
Pageof 21